Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1989-7-5
|
| pubmed:abstractText |
The activity of antimicrobial agents against Fusobacterium species has been reported as variable in the literature. For some strains, the inconsistency arises from difficulty in determining the endpoint of growth in agar dilution susceptibility tests. Certain strains persist as a subtle haze beyond the levels of antibiotic that permit conventional colonial growth. We have determined by light and electron microscopy that this haze represents the colonial growth of cell-wall-defective (CWD) variants of the parent Fusobacterium. The CWD forms could be propagated indefinitely in hypertonic medium containing the antibiotic inducing agent. However, when the antibiotic was eliminated, the organisms would revert to their native morphology. Formation of CWD variants was observed in the presence of cell-wall-active drugs (e.g., beta-lactam agents) but not with drugs that work by a different mechanism (e.g., clindamycin or chloramphenicol). Fourteen of 22 F. varium strains, 8 of 11 F. mortiferum strains, 2 of 10 F. gonidiaformans strains, and 1 of 4 of F. necrophorum strains could be induced to a CWD form in vitro in the usual agar dilution susceptibility test. Although the clinical significance of CWD variants of Fusobacterium is unknown, they may be a source of confusion in interpreting agar dilution susceptibility tests.
|
| pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-16560823,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-3494743,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-3777921,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-4220269,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-4938947,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-5204230,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-5344031,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-541519,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-6712200,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-7025153,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-7325628,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2729931-922598
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0066-4804
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
33
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
369-72
|
| pubmed:dateRevised |
2009-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:2729931-Anti-Bacterial Agents,
pubmed-meshheading:2729931-Cefoxitin,
pubmed-meshheading:2729931-Cell Wall,
pubmed-meshheading:2729931-Fusobacterium,
pubmed-meshheading:2729931-Microbial Sensitivity Tests,
pubmed-meshheading:2729931-Microscopy, Electron,
pubmed-meshheading:2729931-Penicillin G,
pubmed-meshheading:2729931-Spheroplasts
|
| pubmed:year |
1989
|
| pubmed:articleTitle |
Cell-wall-defective variants of Fusobacterium.
|
| pubmed:affiliation |
Medical Service, Veterans Administration Wadsworth Medical Center, Los Angeles, California 90073.
|
| pubmed:publicationType |
Journal Article
|